PECULIARITIES OF EXTERNAL RESPIRATION FUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH DEFICIT OF ALPHA-1-ANTITRYPSIN
https://doi.org/10.21518/2079-701X-2016-15-18-22
Abstract
Chronic obstructive pulmonary disease (COPD) is one of the leading reasons of mortality in the whole world. The insufficiency of alpha-1-antitrypsin (А1АТ) protein is an important factor of genetic predisposition to COPD development. А1АТ deficit can be diagnosed with the help of phenotyping. Detection of PiZZ phenotype of А1АТ preconditions 95% of А1АТ deficit cases whereas PiMM phenotype testifies about the conservation function of the protein. Detection of A1AT in case of COPD might be accompanied by a graver course of the diseases, it is characterized by peculiarities of complex study parameters of the external respiratory function and densitometric values of the pulmonary tissue determined by computer tomography.
The objective of this study is comparison of external respiratory function in COPD patients with PiZZ and PiMM phenotype of А1АТ.
Materials and methods: COPD patients with PiZZ phenotype of А1АТ (N = 6) and PiMM phenotype of A1AT (N = 75) were studies. The following spirometric values were evaluate: forced expiratory volume per 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, maximum expiratory flow rate (MEFR), peak flow rates (PFR50 and PFR75), mean flow rate (MFR), as well as the total lung capacity (TLC) etc. Spiral computer tomography was performed with application of the densitometric analysis software.
Evaluation of the intensity of dyspnoe and effect of symptoms on the quality of life was done.
Results. Comparison of spirometric values showed that for patients at PiZZ phenotype of А1АТ showed lower values of FEV1/ FVC, PFR50, PFR75, MFR, DLco, va and higher parameters of MEFR, FVC and TLC than in PiMM phenotype of А1АТ (p < 0,05*).
Conclusions: in COPD patients with PiZZ phenotype of А1АТ more intense deviations of bronchial obstruction, reduction of elastic properties of the pulmonary tissues, hyperinflation, reduction of the capillary bed due to emphysematous pulmonary involvement are observed.
About the Authors
M. Y. PERVAKOVARussian Federation
O. N. TITOVA
Russian Federation
MD, Prof.
A. A. SHUMILOV
Russian Federation
S. V. LAPIN
Russian Federation
PhD in medicine
E. A. SURKOVA
Russian Federation
PhD in biology
V. L. EMANUEL
Russian Federation
MD, Prof.
References
1. Чучалин А.Г., Овчаренко С.И., Лещенко И.В. и др. Федеральные клинические рекомендации по диагностике и лечению хронической обструктивный болезни легких. РМЖ, 2014, 5: 3-31. [Chuchalin A.G., Ovcharenko S.I., Leschenko I.V. et al. Federal clinical recommendations on diagnostics and therapy of the chronic obstructive pulmonary disease. RMZ, 2014, 5: 3-31].
2. Gomez FP, Rodriguez-Roisin R. Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for chronic obstructive pulmonary disease. Curr Opin Pulm Med, 2002, 8(2): 81-6.
3. WHO. The Global Burden of Disease: 2004 update. Geneva: World Health Organization, 2008.
4. Patel JG, Nagar SP, Dalal AA. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstruct Pulmon Dis, 2014, 9: 289-300.
5. Буйкин СВ, Пузырев ВП. Альфа-1-антитрипсиновая недостаточность. Перспективы скрининга. Сообщение 1. Бюллетень Сибирского отделения Российской академии медицинских наук, 2004, 1: 92-97. [Buykin S.V., Puzyrev V.P. Alpha-1-antitrypsin insufficiency. Prospects of screening. Message 1. Bulletin Sibirskogo Otdelenia Rossiyskoy Akademii Meditsinskykh Nauk, 2004, 1: 92-97].
6. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem, 1983, 52: 655-709.
7. Lockett AD, Van Demark M, Gu Y, Schweitzer KS, Sigua N, Kamocki K et al. Effect of cigarette smoke exposure and structural modifications on the alpha-1 Antitrypsin interaction with caspases. Mol Med, 2012, 18: 445-54.
8. Lockett AD, Kimani S, Ddungu G, Wrenger S, Tuder RM, Janciauskiene SM, Petrache I. alpha(1)-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-alpha. Am J Respir Cell Mol Biol, 2013, 49(1): 143-50.
9. de Serres F, Blanco I. Role of alpha-1 antitrypsin in human health and disease. J Intern Med, 2014.
10. Jonigk D, Al-Omari M, Maegel L, Müller M, Izykowski N, Hong J et al. Anti-inflammatory and immunomodulatory properties of alpha1-antitrypsin without inhibition of elastase. Proc Natl Acad Sci USA, 2013, 110(37): 15007-12.
11. Seixas S, Garcia O, Trovoada MJ, Santos MT, Amorim A, Rocha J. Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism. Hum Genet, 2001, 108(1): 20-30.
12. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med, 2003, 168(7): 818-900.
13. Keren DF. Protein electrophoresis in clinical diagnosis, ed. A. London, 2003: 71-77.
14. Salahuddin P. Genetic variants of alpha1-antitrypsin. Curr Protein Pept Sci, 2010, 11(2): 101-17.
15. Pervakova MY, Emanuel VL, Surkova EA, Mazing AV, Lapin SV, Kovaleva IS, Sysoeva SN. The comparison of techniques of electrophoresis, immune turbidynamic measurement and phenotyping of alpha-1-antitrypsin for diagnostic of alpha-1-antitrypsin insufficiency. Klin Lab Diagn, 2015, 10: 28-31.
16. Kankaanranta H, Harju T, Kilpeläinen M, Mazur W, Lehto JT, Katajisto M, Peisa T, Meinander T, Lehtimäki L. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines. Basic Clin Pharmacol Toxicol, 2015, 116(4): 291-307.
17. Stav D, Raz M. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel. Isr Med Assoc J, 2007, 9(11): 800-2.
18. Видаль Р., Бланко И., Касас Ф. и др. Рекомендации по диагностике и ведению больных с дефицитом α 1 ан титрипсина Испанского общества пульмонологии и торакальнойхирургии (SEPAR). Пульмонология, 2008, 1: 14-28. [Vidal R., Blanco I., Casas F. et al. Recommendations on diagnostics and management of α 1 antitrypsin deficient patients of the Spanish Pulmonology and Thoracic Surgery Society. Pulmonologia, 2008, 1: 14-28].
19. Харитонов МА, Шустов СБ, Куренкова ИГ, Кицышин ВП, Функция внешнего дыхания. Теория и практика. 2013. [Kharitonov M.A., Shustov S.B., Kurenkova I.G., Kitsyshin V.P. External respiratory function. Theory and practice. 2013].
20. Brebner JA, Stockley RA. Recent advances in alpha1antitrypsin deficiency related lung disease. Exp. Rev. Respir. Med., 2013, 7(3): 213230. DOI: 10.1586/ers.13.20.
Review
For citations:
PERVAKOVA MY, TITOVA ON, SHUMILOV AA, LAPIN SV, SURKOVA EA, EMANUEL VL. PECULIARITIES OF EXTERNAL RESPIRATION FUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH DEFICIT OF ALPHA-1-ANTITRYPSIN. Meditsinskiy sovet = Medical Council. 2016;(15):18-22. (In Russ.) https://doi.org/10.21518/2079-701X-2016-15-18-22